{"id":26854,"date":"2019-09-06T06:17:49","date_gmt":"2019-09-06T12:17:49","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=26854"},"modified":"2019-09-11T13:23:19","modified_gmt":"2019-09-11T19:23:19","slug":"animal-health-news-notes-for-september-6-2019","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-september-6-2019\/","title":{"rendered":"NOT\u00cdCIAS E NOTAS DE SA\u00daDE ANIMAL DE 6 DE SETEMBRO DE 2019"},"content":{"rendered":"<p>***********************************<br \/>\n<strong>Brakke Consulting&#039;s<\/strong><br \/>\n<strong>Not\u00edcias e notas de sa\u00fade animal para 6 de setembro<\/strong><strong>, 2019<\/strong><br \/>\n<em>Copyright \u00a9 Brakke Consulting<\/em><\/p>\n<p><em>Editor: Lynn Fondon DVM MBA<br \/>\n<\/em>************************************<\/p>\n<p>NAS NOTICIAS:<\/p>\n<p><u>Novidades da Brakke Consulting<br \/>\n<\/u>Canal OTC<\/p>\n<p><u>Not\u00edcias de Ganhos<br \/>\n<\/u>Dechra<\/p>\n<p><u>Outras not\u00edcias<br \/>\n<\/u>bimeda<br \/>\nbiogal<br \/>\nECO Sa\u00fade Animal<br \/>\nMerck<br \/>\nRestauraPet<\/p>\n<p>***********************************<\/p>\n<p><strong>CONSULTORIA DE FREIO<br \/>\n<\/strong><strong>ENTENDENDO O MERCADO DE BOLSA<\/strong><\/p>\n<p>Se sua empresa est\u00e1 considerando os canais OTC para novas oportunidades de neg\u00f3cios ou voc\u00ea distribui nos canais OTC h\u00e1 anos, a equipe da Brakke Consulting pode fornecer assist\u00eancia significativa e de qualidade para empresas que buscam aprender mais sobre os detalhes dos canais OTC de distribui\u00e7\u00e3o. Se voc\u00ea estiver procurando informa\u00e7\u00f5es significativas sobre os canais OTC, as tend\u00eancias encontradas l\u00e1 e as oportunidades existentes, entre em contato conosco pelo telefone 336-396-3916 ou Joel Adamson em\u00a0<a href=\"mailto:adamson.joel@cox.net\">adamson.joel@cox.net<\/a>.<\/p>\n<p><a href=\"https:\/\/brakkeconsulting.com\/pt\/\">www.BrakkeConsulting.com<\/a><\/p>\n<p>***********************************<\/p>\n<p><strong>RELEASES DE RESULTADOS DA EMPRESA<\/strong><\/p>\n<ul>\n<li><strong>Farmac\u00eautica Dechra<\/strong>\u00a0reportou resultados para o ano fiscal encerrado em 30 de junho de 2019. As vendas foram de GBP 482 milh\u00f5es ($583 milh\u00f5es), um aumento de 18% em rela\u00e7\u00e3o ao ano anterior. Este total incluiu GBP 447,6 milh\u00f5es de neg\u00f3cios existentes da empresa (+10%) e uma contribui\u00e7\u00e3o de GBP 34,2 milh\u00f5es de neg\u00f3cios adquiridos. Na Am\u00e9rica do Norte, as vendas aumentaram em 20% para GBP 178 milh\u00f5es ($215 milh\u00f5es).\u00a0<em>(Farm\u00e1cia Animal)<\/em><\/li>\n<\/ul>\n<p>***********************************<br \/>\n<strong>COMUNICADOS DE NOT\u00cdCIAS DA EMPRESA<\/strong><\/p>\n<ul>\n<li><strong>Merck Sa\u00fade Animal<\/strong>\u00a0recebeu uma licen\u00e7a exclusiva para uma nova vacina contra a febre aftosa (FMD) pelo Instituto Pirbright do Reino Unido e seus parceiros de pesquisa. A nova vacina, baseada em part\u00edculas semelhantes a v\u00edrus (VLPs) que imitam a casca externa do v\u00edrus da febre aftosa e desencadeiam uma resposta imune, foi projetada para proteger o gado contra v\u00e1rios sorotipos do v\u00edrus da febre aftosa. A Pirbright afirma que \u00e9 mais est\u00e1vel do que as vacinas atuais contra a febre aftosa e \u00e9 menos dependente de uma cadeia de frio durante a distribui\u00e7\u00e3o.<em>\u00a0(Farm\u00e1cia Animal)<\/em><\/li>\n<li>A FDA anunciou a aprova\u00e7\u00e3o do\u00a0<strong>bimeda<\/strong>&#039;s EnroMed 100 (inje\u00e7\u00e3o de enrofloxacina gen\u00e9rica) para uso em gado leiteiro e su\u00edno de corte e n\u00e3o lacta\u00e7\u00e3o; e OxyMed LA (inje\u00e7\u00e3o gen\u00e9rica de oxitetraciclina) para uso em su\u00ednos, bovinos de corte, bovinos leiteiros e bezerros.\u00a0<em>(FDA)<\/em><\/li>\n<li><strong>ECO Sa\u00fade Animal<\/strong>\u00a0anunciou uma parceria de pesquisa mundial exclusiva com o The Pirbright Institute, Reino Unido, para desenvolver um novo biof\u00e1rmaco para proteger galinhas do V\u00edrus da Bronquite Infecciosa<em>. (comunicado de imprensa da empresa)<\/em><\/li>\n<li><strong>biogal<\/strong>\u00a0anunciou o lan\u00e7amento do dispositivo port\u00e1til de leitura automatizada CombCam. A CombCam foi projetada para uso com os diagn\u00f3sticos VacciCheck e ImmunoComb da Biogal.\u00a0<em>(Farm\u00e1cia Animal)<\/em><\/li>\n<li><strong>RestauraPet<\/strong>\u00a0anunciou o lan\u00e7amento de novos suplementos de c\u00e2nhamo cl\u00e1ssicos e de espectro total para gatos e cavalos. As f\u00f3rmulas do RestoraPet incluem o Vitalitrol, um \u201csuper antioxidante\u201d patenteado e rejuvenescedor de c\u00e9lulas, que ajuda a restaurar a fun\u00e7\u00e3o ideal dos \u00f3rg\u00e3os de um animal de estima\u00e7\u00e3o no n\u00edvel celular.<em>\u00a0(comunicado de imprensa da empresa)<\/em><\/li>\n<\/ul>\n<p>***********************************<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-26852\" src=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2019\/09\/Stock-Tracker.png\" alt=\"\" width=\"496\" height=\"432\" srcset=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2019\/09\/Stock-Tracker.png 496w, https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2019\/09\/Stock-Tracker-300x261.png 300w\" sizes=\"(max-width: 496px) 100vw, 496px\" \/><\/p>\n<p>***********************************<br \/>\n<strong>NOT\u00cdCIAS DE SA\u00daDE ANIMAL<\/strong><strong>\u00a0<\/strong><\/p>\n<ul>\n<li>EUA \u2013 DOEN\u00c7A DE NEWCASTLE A Calif\u00f3rnia relatou uma nova detec\u00e7\u00e3o da doen\u00e7a virulenta de Newcastle (VND) em uma propriedade no centro do condado de San Diego, a primeira detec\u00e7\u00e3o de VND no condado de San Diego desde o in\u00edcio do incidente em maio de 2018. O condado de San Diego n\u00e3o fazia parte da quarentena regional de VND implementada em fevereiro de 2019. Embora este tenha sido o primeiro caso no condado de San Diego, foi o segundo caso detectado na Calif\u00f3rnia em agosto, ap\u00f3s nenhuma detec\u00e7\u00e3o de VND desde o in\u00edcio de junho.<em>\u00a0(alimentos)<\/em><\/li>\n<li>EUA \u2013 PESQUISA SU\u00cdNA O Instituto Nacional de Alimentos e Agricultura do USDA concedeu \u00e0 Kansas State University $475.000 para apoiar um estudo focado no controle do v\u00edrus da s\u00edndrome respirat\u00f3ria e reprodutiva su\u00edna (PRRS) e v\u00edrus da gripe su\u00edna A (SIAV). O projeto visa obter uma melhor compreens\u00e3o das enzimas isomerases de prote\u00edna dissulfeto como um alvo potencial para o desenvolvimento de estrat\u00e9gias de interven\u00e7\u00e3o contra o v\u00edrus PRRS e SIAV.\u00a0<em>(Farm\u00e1cia Animal)<\/em><\/li>\n<li>FRAN\u00c7A \u2013 DETE\u00c7\u00c3O DE TEMPERATURA Cientistas do Equ&#039;Institut da Fran\u00e7a no Haras du Plessis desenvolveram um aplicativo para trabalhar com um microchip Biothermo que l\u00ea o n\u00famero de identifica\u00e7\u00e3o do cavalo e sua temperatura corporal e envia dados e alertas para propriet\u00e1rios e veterin\u00e1rios em seus smartphones.<em>\u00a0(Vantagem veterin\u00e1ria \u2013 TheHorse.com)<\/em><\/li>\n<\/ul>\n<p>************************************<br \/>\n<strong>PONTO DE VISTA DA BRAKKE CONSULTORIA<\/strong><\/p>\n<p>Estou impressionado com os itens do News &amp; Notes desta semana sobre doen\u00e7as antigas, especialmente a febre aftosa, porque estou preocupado com uma \u201cnova\u201d doen\u00e7a, a peste su\u00edna africana (PSA). Mencionei algumas dessas preocupa\u00e7\u00f5es no Viewpoint algumas semanas atr\u00e1s. Depois de escrever sobre isso, sempre que encontrava colegas da ind\u00fastria, perguntava qual era a probabilidade de a doen\u00e7a chegar aos Estados Unidos. Cada pessoa disse, \u201c100%\u201d. Talvez j\u00e1 esteja aqui \u2013 mas n\u00e3o em porcos.<\/p>\n<p>O \u00faltimo surto de febre aftosa de acordo com o APHIS foi em 1929. Por 90 anos, conseguimos evitar que o v\u00edrus entrasse nos Estados Unidos e causasse o que seria de se esperar uma debilita\u00e7\u00e3o generalizada de rebanhos bovinos e su\u00ednos. Eu era respons\u00e1vel pelo Reino Unido em 2001, quando a febre aftosa atingiu o pa\u00eds e enquanto 2.000 animais morreram, 4 milh\u00f5es foram abatidos, de acordo com o governo do Reino Unido. Mas h\u00e1 relat\u00f3rios da Comiss\u00e3o de Carne e Pecu\u00e1ria do Reino Unido de que o total de animais mortos no Reino Unido devido \u00e0 febre aftosa estava pr\u00f3ximo de 19 milh\u00f5es. Lembro-me da devasta\u00e7\u00e3o que causou \u00e0 ind\u00fastria e \u00e0s pessoas que criaram os animais e espero que nunca chegue aqui.<\/p>\n<p>O Rabobank estima que a popula\u00e7\u00e3o de su\u00ednos da China no ano passado foi de 360 milh\u00f5es e que este ano metade deles seria abatida para PSA, ou cerca de 200 milh\u00f5es. Levar\u00e1 anos para reabastecer e, quando o fizerem, parecer\u00e1 muito diferente. \u00c9 dif\u00edcil obter bons n\u00fameros da China, mas pelo menos s\u00e3o n\u00fameros grandes.<\/p>\n<p>De volta \u00e0s not\u00edcias desta semana: o USDA est\u00e1 concedendo bolsas KSU para estudar PRRS e SIAV e ainda estamos lidando com doen\u00e7as virais antigas de aves. Nenhuma not\u00edcia sobre a vacina contra a PSA esta semana. No in\u00edcio deste ano e no final do ano passado, no entanto, o USDA concedeu licen\u00e7as exclusivas de patentes de tecnologia de vacina contra a PSA a duas empresas (Zoetis e Huvepharma). N\u00e3o dever\u00edamos estar ouvindo com mais frequ\u00eancia sobre o desenvolvimento da vacina contra a PSA? Algumas das novas tecnologias de vacinas n\u00e3o s\u00e3o adequadas para o v\u00edrus da PSA?<\/p>\n<p>A biosseguran\u00e7a aprimorada e forte ajudar\u00e1 a impedir a propaga\u00e7\u00e3o da doen\u00e7a da PSA nos EUA. Mantivemos a febre aftosa fora por muito tempo. Eu gostaria de divulgar as novas e eficazes vacinas contra a PSA... e em breve.<\/p>\n<p><em>Bob Jones<\/em><em><br \/>\n<\/em><\/p>\n<p>**********************************<\/p>\n<p>Problemas para visualizar esta newsletter? Voc\u00ea pode visualiz\u00e1-lo online em\u00a0<a href=\"https:\/\/brakkeconsulting.com\/pt\/\">www.BrakkeConsulting.com<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><em>Este boletim eletr\u00f4nico \u00e9 propriedade exclusiva da Brakke Consulting.<br \/>\nQualquer uso do conte\u00fado deste documento deve ser aprovado e devidamente atribu\u00eddo \u00e0 Brakke Consulting.<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>Para obter mais informa\u00e7\u00f5es sobre os servi\u00e7os e estudos sindicados da Brakke Consulting, visite nosso website em\u00a0<a href=\"https:\/\/brakkeconsulting.com\/pt\/\">www.brakkeconsulting.com<\/a>.<br \/>\nBrakke Consultoria<\/p>\n<p>Rua Green Valley, 806<br \/>\nSu\u00edte 200<br \/>\nGreensboro, NC 27408<\/p>","protected":false},"excerpt":{"rendered":"<p>*********************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 6 de setembro de 2019 Copyright \u00a9 Brakke Editora de Consultoria: Lynn Fondon DVM MBA ************************************ NAS NOT\u00cdCIAS: Not\u00edcias da Brakke Consulting Not\u00edcias de ganhos do canal OTC Dechra Outras not\u00edcias Bimeda Biogal ECO Sa\u00fade Animal Merck RestoraPet *********************************** BRAKKE CONSULTORIA COMPREENDENDO O MERCADO DE Balc\u00e3o Quer sua empresa esteja considerando os canais OTC para novas oportunidades de neg\u00f3cios ou voc\u00ea j\u00e1 distribua nos canais OTC h\u00e1 anos, a equipe da Brakke Consulting pode fornecer assist\u00eancia significativa e de qualidade para empresas que buscam aprender mais sobre o mercado de balc\u00e3o. detalhes dos canais de distribui\u00e7\u00e3o OTC. Se voc\u00ea estiver procurando informa\u00e7\u00f5es significativas sobre os canais OTC, as tend\u00eancias encontradas neles e as oportunidades que existem, entre em contato conosco pelo telefone 336-396-3916 ou Joel Adamson pelo e-mail adamson.joel@cox.net. www.BrakkeConsulting.com *********************************** DIVULGA\u00c7\u00d5ES DE GANHOS DA EMPRESA A Dechra Pharmaceuticals relatou resultados de seu faturamento fiscal ano encerrado em 30 de junho de 2019. As vendas foram de GBP 482 milh\u00f5es ($583 milh\u00f5es), um aumento de 18% em rela\u00e7\u00e3o ao ano anterior. Este total incluiu 447,6 milh\u00f5es de libras esterlinas provenientes dos neg\u00f3cios existentes da empresa (+10%) e uma contribui\u00e7\u00e3o de 34,2 milh\u00f5es de libras esterlinas de neg\u00f3cios adquiridos. Na Am\u00e9rica do Norte, as vendas aumentaram em 20% para 178 milh\u00f5es de libras esterlinas ($215 milh\u00f5es). (Animal Pharm) *********************************** COMUNICADOS DE NOT\u00cdCIAS DA EMPRESA A Merck Animal Health recebeu um exclusivo licen\u00e7a para uma nova vacina contra a febre aftosa (FA) pelo Instituto Pirbright do Reino Unido e seus parceiros de investiga\u00e7\u00e3o. O<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-september-6-2019\/\" class=\"view-full-post-btn\">Ver postagem completa<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-26854","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-september-6-2019\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"*********************************** Brakke Consulting\u2019s Animal Health News &amp; Notes for September 6, 2019 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Brakke Consulting news OTC Channel Earnings News Dechra Other News Bimeda Biogal ECO Animal Health Merck RestoraPet *********************************** BRAKKE CONSULTING UNDERSTANDING THE OVER-THE-COUNTER MARKET Whether your business is considering the OTC channels for new business opportunities or you have been distributing in the OTC channels for years, Brakke Consulting\u2019s team can provide significant and quality assistance to businesses seeking to learn more about the details of the OTC channels of distribution.\u00a0 If you are looking for meaningful insights into the OTC channels, the trends found there, and the opportunities that exist, contact us at 336-396-3916 or Joel Adamson at\u00a0adamson.joel@cox.net. www.BrakkeConsulting.com *********************************** COMPANY EARNINGS RELEASES Dechra Pharmaceuticals\u00a0reported results for its fiscal year ended June 30, 2019. Sales were GBP 482 million ($583 million), an increase of 18% over the prior year. This total included GBP 447.6 million from the company\u2019s existing business (+10%) and a GBP 34.2 million contribution from acquired businesses. In North America, sales were up by 20% to GBP 178 million ($215 million).\u00a0(Animal Pharm) *********************************** COMPANY NEWS RELEASES Merck Animal Health\u00a0has been granted an exclusive license for a new foot-and-mouth disease (FMD) vaccine by the UK\u2019s Pirbright Institute and its research partners. TheView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-september-6-2019\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-06T12:17:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-09-11T19:23:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2019\/09\/Stock-Tracker.png\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"ANIMAL HEALTH NEWS &#038; NOTES FOR SEPTEMBER 6, 2019\",\"datePublished\":\"2019-09-06T12:17:49+00:00\",\"dateModified\":\"2019-09-11T19:23:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/\"},\"wordCount\":1061,\"image\":{\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2019\/09\/Stock-Tracker.png\",\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/\",\"url\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2019\/09\/Stock-Tracker.png\",\"datePublished\":\"2019-09-06T12:17:49+00:00\",\"dateModified\":\"2019-09-11T19:23:19+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/#primaryimage\",\"url\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2019\/09\/Stock-Tracker.png\",\"contentUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2019\/09\/Stock-Tracker.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANIMAL HEALTH NEWS &#038; NOTES FOR SEPTEMBER 6, 2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-september-6-2019\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"*********************************** Brakke Consulting\u2019s Animal Health News &amp; Notes for September 6, 2019 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Brakke Consulting news OTC Channel Earnings News Dechra Other News Bimeda Biogal ECO Animal Health Merck RestoraPet *********************************** BRAKKE CONSULTING UNDERSTANDING THE OVER-THE-COUNTER MARKET Whether your business is considering the OTC channels for new business opportunities or you have been distributing in the OTC channels for years, Brakke Consulting\u2019s team can provide significant and quality assistance to businesses seeking to learn more about the details of the OTC channels of distribution.\u00a0 If you are looking for meaningful insights into the OTC channels, the trends found there, and the opportunities that exist, contact us at 336-396-3916 or Joel Adamson at\u00a0adamson.joel@cox.net. www.BrakkeConsulting.com *********************************** COMPANY EARNINGS RELEASES Dechra Pharmaceuticals\u00a0reported results for its fiscal year ended June 30, 2019. Sales were GBP 482 million ($583 million), an increase of 18% over the prior year. This total included GBP 447.6 million from the company\u2019s existing business (+10%) and a GBP 34.2 million contribution from acquired businesses. In North America, sales were up by 20% to GBP 178 million ($215 million).\u00a0(Animal Pharm) *********************************** COMPANY NEWS RELEASES Merck Animal Health\u00a0has been granted an exclusive license for a new foot-and-mouth disease (FMD) vaccine by the UK\u2019s Pirbright Institute and its research partners. TheView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/animal-health-news-notes-for-september-6-2019\/","og_site_name":"Brakke Consulting Website","article_published_time":"2019-09-06T12:17:49+00:00","article_modified_time":"2019-09-11T19:23:19+00:00","og_image":[{"url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2019\/09\/Stock-Tracker.png","type":"","width":"","height":""}],"author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"ANIMAL HEALTH NEWS &#038; NOTES FOR SEPTEMBER 6, 2019","datePublished":"2019-09-06T12:17:49+00:00","dateModified":"2019-09-11T19:23:19+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/"},"wordCount":1061,"image":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/#primaryimage"},"thumbnailUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2019\/09\/Stock-Tracker.png","articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/","url":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/#primaryimage"},"image":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/#primaryimage"},"thumbnailUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2019\/09\/Stock-Tracker.png","datePublished":"2019-09-06T12:17:49+00:00","dateModified":"2019-09-11T19:23:19+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/#primaryimage","url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2019\/09\/Stock-Tracker.png","contentUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2019\/09\/Stock-Tracker.png"},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/animal-health-news-notes-for-september-6-2019\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"ANIMAL HEALTH NEWS &#038; NOTES FOR SEPTEMBER 6, 2019"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/26854","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=26854"}],"version-history":[{"count":3,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/26854\/revisions"}],"predecessor-version":[{"id":26857,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/26854\/revisions\/26857"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=26854"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=26854"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=26854"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}